Tubulización gástrica endoscópica (Endosleeve)
Endoscopic gastric tubulization is currently proposed in the Digestive Surgery Department of the Nouvel Hôpital Civil, Strasbourg, France, to adult patients with morbid obesity. The procedure is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). It is standard practice since October 2016.
The objective of this study is to prospectively collect data of patients who underwent an endoscopic gastric tubulization, from last visit before procedure to 2 years after procedure. These data are usually collected during medical consultations and will enable the evaluation of weight loss, quality of life and comorbidities improvement, reproducibility and durability of the technique.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Gastric restriction is one of the fundamental principles of gastric bypass and gastric banding. Despite its advantages (long term weight loss, comorbidities related to obesity improvement…), bariatric surgery is risky. In fact, complications putting the patient into a life-threatening condition can occur. Endoscopic approaches are similar to current surgical methods but less invasive, safer and allow ambulatory care.
Nowadays, practitioners have the possibility to reduce stomach size by merging tissues through an endoscopic endoluminal suture approach without any incision. This leads to similar results (gastric restriction, weight loss, quality of life and comorbidities improvement) compared with standard surgical procedure while reducing the risk of complications.
One of the major benefit of this technique is its reversibility. A new surgical or endoscopic procedure is possible at a later stage.
Endoscopic gastric tubulization is currently proposed in the Digestive Surgery Department of the Nouvel Hôpital Civil, Strasbourg, France, to adult patients with morbid obesity. The procedure is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). It is standard practice since October 2016.
The objective of this study is to prospectively collect data of patients who underwent an endoscopic gastric tubulization, from last visit before procedure to 2 years after procedure. These data are usually collected during medical consultations and will enable the evaluation of weight loss, quality of life and comorbidities improvement, reproducibility and durability of the technique.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Silvana Perretta, MD, PhD
- Número de teléfono: + 33 3 69 55 05 31
- Correo electrónico: silvana.perretta@ircad.fr
Copia de seguridad de contactos de estudio
- Nombre: Michel Vix, MD
- Número de teléfono: + 33 3 69 55 13 03
- Correo electrónico: michel.vix@chru-strasbourg.fr
Ubicaciones de estudio
-
-
-
Strasbourg, Francia, 67091
- Reclutamiento
- Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil
-
Contacto:
- Silvana Perretta, MD, PhD
- Número de teléfono: + 33 3 69 55 05 31
- Correo electrónico: silvana.perretta@ircad.fr
-
Contacto:
- Michel Vix, MD
- Número de teléfono: +33 3 69 55 13 09
- Correo electrónico: michel.vix@chru-strasbourg.fr
-
Investigador principal:
- Silvana Perretta, MD, PhD
-
Sub-Investigador:
- Antonio D'Urso, MD
-
Investigador principal:
- Michel Vix, MD
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Patients over 18 years old requiring a treatment for morbid obesity.
Descripción
Inclusion Criteria:
- Patients scheduled for an endoscopic gastric tubulization in the Nouvel Hôpital Civil, Strasbourg, France
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Endoscopic gastric tubulization
Endoscopic gastric tubulization is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). |
Endoscopic gastric tubulization is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in weight loss
Periodo de tiempo: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Change in weight loss measured in kilograms. |
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
|
Change in excess weight loss
Periodo de tiempo: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Change in excess weight loss measured in percentage. Excess weight loss = (weight loss at time point / weight loss goal to reach a body mass index of 25 kg/m²) x 100 |
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
|
Change in body mass index variation
Periodo de tiempo: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Change in body mass index variation measured in kg/m². |
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of patients with procedure-related adverse event
Periodo de tiempo: 7 days, 1 - 3 - 6 - 9 and 12 months after procedure
|
Number of patients with procedure-related adverse event within 12 months after procedure. |
7 days, 1 - 3 - 6 - 9 and 12 months after procedure
|
|
Comorbidities improvement
Periodo de tiempo: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Improvement of sleep apnea, arterial hypertension, diabetes, reflux, osteoarticular disorders compared with preoperative data. |
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
|
Quality of life improvement
Periodo de tiempo: 3 - 12 - 18 and 24 months after procedure
|
Improvement of quality of life assessed by Moorehead-Ardelt Quality of Life questionnaire II. Score range from -3.0 to 3.0.
|
3 - 12 - 18 and 24 months after procedure
|
|
Gastro-intestinal quality of life improvement
Periodo de tiempo: 3 - 12 - 18 and 24 months after procedure
|
Improvement of quality of life assessed by the Gastro-Intestinal Quality of Life Index questionnaire. A global score > 125 is considered as normal. |
3 - 12 - 18 and 24 months after procedure
|
|
Modification in the feeling of satiety
Periodo de tiempo: 1 - 3 - 6 - 12 - 18 and 24 months after procedure
|
Satiety assessed by Three Factors Eating Questionnaire - R18. Three dimensions are assessed. The higher the score is, the more important the dimension is.
|
1 - 3 - 6 - 12 - 18 and 24 months after procedure
|
|
Upper GI tract radiologic evaluation
Periodo de tiempo: 1 day, 6 - 12 and 24 months after procedure
|
Upper GI control series. |
1 day, 6 - 12 and 24 months after procedure
|
|
Upper GI tract endoscopic evaluation
Periodo de tiempo: 6 - 12 and 24 months after procedure
|
Upper GI control gastroscopy. |
6 - 12 and 24 months after procedure
|
|
Procedure duration
Periodo de tiempo: At time of procedure
|
Time required to perform the endoscopic gastric tubulization. |
At time of procedure
|
|
Number of stitches in place
Periodo de tiempo: At time of procedure
|
Number of stitches put in place during the endoscopic gastric tubulization. |
At time of procedure
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Michel Vix, MD, Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
- Investigador principal: Silvana Perretta, MD, PhD, Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
Publicaciones y enlaces útiles
Publicaciones Generales
- Lopez-Nava G, Galvao MP, da Bautista-Castano I, Jimenez A, De Grado T, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015 May;47(5):449-52. doi: 10.1055/s-0034-1390766. Epub 2014 Nov 7.
- Lopez-Nava G, Galvao MP, Bautista-Castano I, Jimenez-Banos A, Fernandez-Corbelle JP. Endoscopic Sleeve Gastroplasty: How I Do It? Obes Surg. 2015 Aug;25(8):1534-8. doi: 10.1007/s11695-015-1714-7.
- Lopez-Nava G, Galvao M, Bautista-Castano I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016 Feb;4(2):E222-7. doi: 10.1055/s-0041-110771. Epub 2016 Jan 15.
- Sharaiha RZ, Kedia P, Kumta N, DeFilippis EM, Gaidhane M, Shukla A, Aronne LJ, Kahaleh M. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2015 Feb;47(2):164-6. doi: 10.1055/s-0034-1390773. Epub 2014 Nov 7.
- Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013 Sep;78(3):530-5. doi: 10.1016/j.gie.2013.04.197. Epub 2013 May 24.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- 16-001-OBS (CPP)
- 2017-A03599-44 (Otro identificador: ANSM France)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .